Takeda Pharma A/S — China drug registrations and re-registration deadlines
10 certificates in the NMPA overseas-manufactured drug database (境外生产药品库), snapshot 2026-06-28. Earliest re-registration deadline: 2026-09-21.
| Approval number | Product | Certificate expires | Re-registration deadline (Art. 82) |
|---|---|---|---|
| 国药准字HJ20220019 | ALUNBRIG 布格替尼片 | 2027-03-21 | 2026-09-21 |
| 国药准字HJ20220020 | ALUNBRIG 布格替尼片 | 2027-03-21 | 2026-09-21 |
| 国药准字HJ20220021 | ALUNBRIG 布格替尼片 | 2027-03-21 | 2026-09-21 |
| 国药准字HJ20180010 | Ninlaro 枸橼酸伊沙佐米胶囊 | 2028-02-13 | 2027-08-13 |
| 国药准字HJ20180011 | Ninlaro 枸橼酸伊沙佐米胶囊 | 2028-02-13 | 2027-08-13 |
| 国药准字HJ20180012 | Ninlaro 枸橼酸伊沙佐米胶囊 | 2028-02-13 | 2027-08-13 |
| 国药准字SJ20200006 | Entyvio 注射用维得利珠单抗 | 2029-11-10 | 2029-05-10 |
| 国药准字SJ20200008 | ADCETRIS 注射用维布妥昔单抗 | 2030-02-06 | 2029-08-06 |
| 国药准字HJ20210003 | Edarbi 美阿沙坦钾片 | 2030-11-09 | 2030-05-09 |
| 国药准字HJ20210004 | Edarbi 美阿沙坦钾片 | 2030-11-09 | 2030-05-09 |
Under the Provisions for Drug Registration (药品注册管理办法) Art. 82, an application to renew an overseas-manufactured drug registration is filed with the Center for Drug Evaluation no later than 6 months before the certificate expires; the filing line column is that arithmetic applied to the expiry cell. Art. 84(1): a certificate with no application by expiry is not re-registered and is cancelled at expiry. Every figure is taken from the public NMPA database as of 2026-06-28, or computed from it. Registration data changes; the NMPA portal governs. This page states no view on whether any of these products' Domestic Responsible Person (境内责任人) arrangements meet NMPA Announcement No. 137 — that cannot be determined from a public entry.